Publicaciones

Desde los principios del Proyecto Genomas Raros en 2017, sus objetivos han sido tres:

  1. Identificar diagnósticos genéticos en favor de familias.
  2. Contribuir a los conocimientos del papel que desempeñan los genes en las enfermedades humanas.
  3. Diseñar métodos, identificar procesos y aplicar tecnologías (por ejemplo, la secuenciación del ARN y la secuenciación de lecturas largas) que mejoren las capacidades diagnósticas de la secuenciación del genoma.

A continuación encontrará enlaces a publicaciones y preimpresiones acerca de nuestro trabajo. Este trabajo no sería posible sin los esfuerzos y aportaciones de las familias que participan en el Proyecto Genomas Raros. Agradecemos la oportunidad de colaborar con usted en la búsqueda de los diagnósticos genéticos de usted o de sus seres queridos.

Última actualización: mayo de 2025

Pre-print

 

Loss-of-function of the Zinc Finger Homeobox 4 (ZFHX4) gene underlies a neurodevelopmental disorder, 2024. PMID pre-print: 39148819.

Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity, 2024. PMID pre-print: 38978649.

Mitochondrial DNA variant detection in rare disease families by systematic analysis of exome, genome, and RNA sequencing data, 2024. PMID pre-print: 39763565.

Mono and biallelic variants in HCN2 cause severe neurodevelopmental disorders, 2024. PMID pre-print: 38562733.

Identification of a de novo mutation in TLK1 associated with a neurodevelopmental disorder and immunodeficiency, 2023. PMID pre-print: 37662408.


2025

 

Mitochondrial DNA variant detection in over 6,500 rare disease families by the systematic analysis of exome and genome sequencing data resolves undiagnosed cases, 2025. PMID: 40241304.

Male proband with intractable seizures and a de novo start-codon-disrupting variant in GLUL, 2025. PMID: 39985170.

Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection, 2025. PMID: 39862869.

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing data sets, 2025. PMID: 39670433.


2024

 

 ARID1B-related disorder in 87 adults: Natural history and self-sustainability, 2024. PMID: 39669611.

HMGCS1 variants cause rigid spine syndrome amenable to mevalonic acid treatment in an animal model, 2024. PMID: 39531736.

Neurodevelopmental Disorder Caused by Deletion of CHASERR, a lncRNA Gene, 2024. PMID: 39442041.

De novo AHDC1 Deletions Identified by Genome Sequencing in Two Individuals with Xia-Gibbs Syndrome, 2024. PMID: 39359946.

Protein-extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation, 2024. PMID: 39095936.

Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes, 2024. PMID: 39013459.

De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome, 2024. PMID: 38991538.

De novo TLK1 and MDM1 mutations in a patient with a neurodevelopmental disorder and immunodeficiency, 2024. PMID: 38868186.

Genome Sequencing for Diagnosing Rare Diseases, 2024. PMID: 38838312.

Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project, 2024. PMID: 38685113.

Neurodevelopmental disorders associated variants in ADAT3 disrupt the activity of the ADAT2/ADAT3 tRNA deaminase complex and impair neuronal migration, 2024. PMID: 38496416.

Heterozygous MAP3K20 variants cause ectodermal dysplasia, craniosynostosis, sensorineural hearing loss, and limb anomalies, 2024. PMID: 38451290.

Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy, 2024. PMID: 38429495.

Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability, 2024. PMID: 38412861.

Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy, 2024. PMID: 38311799.


2023

 

DNM1L variant presenting as adolescent-onset sensory neuronopathy, spasticity, dystonia, and ataxia, 2023. PMID: 38481935.

Advancing Understanding of Inequities in Rare Disease Genomics, 2023. PMID: 37517917.

LHX2 haploinsufficiency causes a variable neurodevelopmental disorder, 2023. PMID: 37057675.

Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly, 2023. PMID: 36724785.


2022

 

Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain, 2022. PMID: 35934918.

Discovering a new part of the phenotypic spectrum of Coffin-Siris syndrome in a fetal cohort, 2022. PMID: 35579625.

Delineation of a novel neurodevelopmental syndrome associated with PAX5 haploinsufficiency, 2022. PMID: 35094443.

Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes, 2022. PMID: 34954817.


2021

 

Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy, 2021. PMID: 34415322.

KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating, 2021. PMID: 34245260.

Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders, 2021. PMID: 34186028.

Germline mutation in POLR2A: a heterogeneous, multi-systemic developmental disorder characterized by transcriptional dysregulation, 2021. PMID: 33665635.

DLG4-related synaptopathy: a new rare brain disorder, 2021. PMID: 33597769.

Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia, 2021. PMID: 33473207.

Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly, 2021. PMID: 33220177.